世界の好酸球性肉芽腫症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Eosinophilic Granulomatosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4194
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、好酸球性肉芽腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メポリズマブ、リツキシマブ、ベンラリズマブ、オマリズマブ、メトトレキサートナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・好酸球性肉芽腫症治療の市場動向
・企業の競争状況、市場シェア
・好酸球性肉芽腫症治療の種類別市場規模と予測2016-2027（メポリズマブ、リツキシマブ、ベンラリズマブ、オマリズマブ、メトトレキサートナトリウム、その他）
・好酸球性肉芽腫症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・好酸球性肉芽腫症治療の北米市場規模2016-2027（アメリカ、カナダ）
・好酸球性肉芽腫症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・好酸球性肉芽腫症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・好酸球性肉芽腫症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・好酸球性肉芽腫症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca plc、GlaxoSmithKline LLC、Baxter Healthcare Corporation、Genentech Inc、Teva Pharmaceutical Industries Ltd、Koninklijke DSM NV、Novartis International AG、Pharma Holdings）
・結論

Eosinophilic Granulomatosis is a rare autoimmune disease usually characterized by acute asthma, vascular inflammation, and high levels of eosinophilic granulosis.Eosinophilic granulomatosis affects various organs such as the lungs, skin, gastrointestinal tract, heart, and nervous system.Eosinophilic granuloma is divided into three stages, namely, allergic, eosinophilic, and vascular.Eosinophilic granulomatosis begins with the development of allergies and asthma

Market Analysis and Insights: Global Eosinophilic Granulomatosis Treatment Market
The global Eosinophilic Granulomatosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eosinophilic Granulomatosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eosinophilic Granulomatosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eosinophilic Granulomatosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eosinophilic Granulomatosis Treatment market.

Global Eosinophilic Granulomatosis Treatment Scope and Market Size
Eosinophilic Granulomatosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Granulomatosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Drug Type
Mepolizumab
Rituximab
Benralizumab
Omalizumab
Methotrexate Sodium
Others
By Route of Administration
Oral
Intravenous
Intramuscular

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca plc
GlaxoSmithKline LLC
Baxter Healthcare Corporation
Genentech Inc
Teva Pharmaceutical Industries Ltd
Koninklijke DSM NV
Novartis International AG
Pharma Holdings

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Granulomatosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mepolizumab
1.2.3 Rituximab
1.2.4 Benralizumab
1.2.5 Omalizumab
1.2.6 Methotrexate Sodium
1.2.7 Others
1.3 Market by Application
1.3.1 Global Eosinophilic Granulomatosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Eosinophilic Granulomatosis Treatment Market Perspective (2016-2027)
2.2 Eosinophilic Granulomatosis Treatment Growth Trends by Regions
2.2.1 Eosinophilic Granulomatosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eosinophilic Granulomatosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Eosinophilic Granulomatosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Eosinophilic Granulomatosis Treatment Industry Dynamic
2.3.1 Eosinophilic Granulomatosis Treatment Market Trends
2.3.2 Eosinophilic Granulomatosis Treatment Market Drivers
2.3.3 Eosinophilic Granulomatosis Treatment Market Challenges
2.3.4 Eosinophilic Granulomatosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Eosinophilic Granulomatosis Treatment Players by Revenue
3.1.1 Global Top Eosinophilic Granulomatosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Eosinophilic Granulomatosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Eosinophilic Granulomatosis Treatment Revenue
3.4 Global Eosinophilic Granulomatosis Treatment Market Concentration Ratio
3.4.1 Global Eosinophilic Granulomatosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eosinophilic Granulomatosis Treatment Revenue in 2020
3.5 Eosinophilic Granulomatosis Treatment Key Players Head office and Area Served
3.6 Key Players Eosinophilic Granulomatosis Treatment Product Solution and Service
3.7 Date of Enter into Eosinophilic Granulomatosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Eosinophilic Granulomatosis Treatment Breakdown Data by Type
4.1 Global Eosinophilic Granulomatosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Eosinophilic Granulomatosis Treatment Forecasted Market Size by Type (2022-2027)

5 Eosinophilic Granulomatosis Treatment Breakdown Data by Application
5.1 Global Eosinophilic Granulomatosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Eosinophilic Granulomatosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Eosinophilic Granulomatosis Treatment Market Size (2016-2027)
6.2 North America Eosinophilic Granulomatosis Treatment Market Size by Type
6.2.1 North America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2027)
6.3 North America Eosinophilic Granulomatosis Treatment Market Size by Application
6.3.1 North America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2027)
6.4 North America Eosinophilic Granulomatosis Treatment Market Size by Country
6.4.1 North America Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Eosinophilic Granulomatosis Treatment Market Size (2016-2027)
7.2 Europe Eosinophilic Granulomatosis Treatment Market Size by Type
7.2.1 Europe Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2027)
7.3 Europe Eosinophilic Granulomatosis Treatment Market Size by Application
7.3.1 Europe Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2027)
7.4 Europe Eosinophilic Granulomatosis Treatment Market Size by Country
7.4.1 Europe Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type
8.2.1 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application
8.3.1 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Region
8.4.1 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Eosinophilic Granulomatosis Treatment Market Size (2016-2027)
9.2 Latin America Eosinophilic Granulomatosis Treatment Market Size by Type
9.2.1 Latin America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Eosinophilic Granulomatosis Treatment Market Size by Application
9.3.1 Latin America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Eosinophilic Granulomatosis Treatment Market Size by Country
9.4.1 Latin America Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type
10.2.1 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application
10.3.1 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Country
10.4.1 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Details
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Eosinophilic Granulomatosis Treatment Introduction
11.1.4 AstraZeneca plc Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.1.5 AstraZeneca plc Recent Development
11.2 GlaxoSmithKline LLC
11.2.1 GlaxoSmithKline LLC Company Details
11.2.2 GlaxoSmithKline LLC Business Overview
11.2.3 GlaxoSmithKline LLC Eosinophilic Granulomatosis Treatment Introduction
11.2.4 GlaxoSmithKline LLC Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline LLC Recent Development
11.3 Baxter Healthcare Corporation
11.3.1 Baxter Healthcare Corporation Company Details
11.3.2 Baxter Healthcare Corporation Business Overview
11.3.3 Baxter Healthcare Corporation Eosinophilic Granulomatosis Treatment Introduction
11.3.4 Baxter Healthcare Corporation Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.3.5 Baxter Healthcare Corporation Recent Development
11.4 Genentech Inc
11.4.1 Genentech Inc Company Details
11.4.2 Genentech Inc Business Overview
11.4.3 Genentech Inc Eosinophilic Granulomatosis Treatment Introduction
11.4.4 Genentech Inc Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.4.5 Genentech Inc Recent Development
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Company Details
11.5.2 Teva Pharmaceutical Industries Ltd Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd Eosinophilic Granulomatosis Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Ltd Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Ltd Recent Development
11.6 Koninklijke DSM NV
11.6.1 Koninklijke DSM NV Company Details
11.6.2 Koninklijke DSM NV Business Overview
11.6.3 Koninklijke DSM NV Eosinophilic Granulomatosis Treatment Introduction
11.6.4 Koninklijke DSM NV Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.6.5 Koninklijke DSM NV Recent Development
11.7 Novartis International AG
11.7.1 Novartis International AG Company Details
11.7.2 Novartis International AG Business Overview
11.7.3 Novartis International AG Eosinophilic Granulomatosis Treatment Introduction
11.7.4 Novartis International AG Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.7.5 Novartis International AG Recent Development
11.8 Pharma Holdings
11.8.1 Pharma Holdings Company Details
11.8.2 Pharma Holdings Business Overview
11.8.3 Pharma Holdings Eosinophilic Granulomatosis Treatment Introduction
11.8.4 Pharma Holdings Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021)
11.8.5 Pharma Holdings Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Eosinophilic Granulomatosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mepolizumab
Table 3. Key Players of Rituximab
Table 4. Key Players of Benralizumab
Table 5. Key Players of Omalizumab
Table 6. Key Players of Methotrexate Sodium
Table 7. Key Players of Others
Table 8. Global Eosinophilic Granulomatosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Eosinophilic Granulomatosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Eosinophilic Granulomatosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Eosinophilic Granulomatosis Treatment Market Share by Regions (2016-2021)
Table 12. Global Eosinophilic Granulomatosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Eosinophilic Granulomatosis Treatment Market Share by Regions (2022-2027)
Table 14. Eosinophilic Granulomatosis Treatment Market Trends
Table 15. Eosinophilic Granulomatosis Treatment Market Drivers
Table 16. Eosinophilic Granulomatosis Treatment Market Challenges
Table 17. Eosinophilic Granulomatosis Treatment Market Restraints
Table 18. Global Eosinophilic Granulomatosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Eosinophilic Granulomatosis Treatment Market Share by Players (2016-2021)
Table 20. Global Top Eosinophilic Granulomatosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Granulomatosis Treatment as of 2020)
Table 21. Ranking of Global Top Eosinophilic Granulomatosis Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Eosinophilic Granulomatosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Eosinophilic Granulomatosis Treatment Product Solution and Service
Table 25. Date of Enter into Eosinophilic Granulomatosis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Eosinophilic Granulomatosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Eosinophilic Granulomatosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Eosinophilic Granulomatosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. AstraZeneca plc Company Details
Table 66. AstraZeneca plc Business Overview
Table 67. AstraZeneca plc Eosinophilic Granulomatosis Treatment Product
Table 68. AstraZeneca plc Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 69. AstraZeneca plc Recent Development
Table 70. GlaxoSmithKline LLC Company Details
Table 71. GlaxoSmithKline LLC Business Overview
Table 72. GlaxoSmithKline LLC Eosinophilic Granulomatosis Treatment Product
Table 73. GlaxoSmithKline LLC Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 74. GlaxoSmithKline LLC Recent Development
Table 75. Baxter Healthcare Corporation Company Details
Table 76. Baxter Healthcare Corporation Business Overview
Table 77. Baxter Healthcare Corporation Eosinophilic Granulomatosis Treatment Product
Table 78. Baxter Healthcare Corporation Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 79. Baxter Healthcare Corporation Recent Development
Table 80. Genentech Inc Company Details
Table 81. Genentech Inc Business Overview
Table 82. Genentech Inc Eosinophilic Granulomatosis Treatment Product
Table 83. Genentech Inc Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 84. Genentech Inc Recent Development
Table 85. Teva Pharmaceutical Industries Ltd Company Details
Table 86. Teva Pharmaceutical Industries Ltd Business Overview
Table 87. Teva Pharmaceutical Industries Ltd Eosinophilic Granulomatosis Treatment Product
Table 88. Teva Pharmaceutical Industries Ltd Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 89. Teva Pharmaceutical Industries Ltd Recent Development
Table 90. Koninklijke DSM NV Company Details
Table 91. Koninklijke DSM NV Business Overview
Table 92. Koninklijke DSM NV Eosinophilic Granulomatosis Treatment Product
Table 93. Koninklijke DSM NV Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 94. Koninklijke DSM NV Recent Development
Table 95. Novartis International AG Company Details
Table 96. Novartis International AG Business Overview
Table 97. Novartis International AG Eosinophilic Granulomatosis Treatment Product
Table 98. Novartis International AG Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 99. Novartis International AG Recent Development
Table 100. Pharma Holdings Company Details
Table 101. Pharma Holdings Business Overview
Table 102. Pharma Holdings Revenue in Eosinophilic Granulomatosis Treatment Business (2016-2021) & (US$ Million)
Table 103. Pharma Holdings Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eosinophilic Granulomatosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mepolizumab Features
Figure 3. Rituximab Features
Figure 4. Benralizumab Features
Figure 5. Omalizumab Features
Figure 6. Methotrexate Sodium Features
Figure 7. Others Features
Figure 8. Global Eosinophilic Granulomatosis Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Eosinophilic Granulomatosis Treatment Report Years Considered
Figure 13. Global Eosinophilic Granulomatosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Eosinophilic Granulomatosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Eosinophilic Granulomatosis Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Eosinophilic Granulomatosis Treatment Market Share by Regions (2022-2027)
Figure 17. Global Eosinophilic Granulomatosis Treatment Market Share by Players in 2020
Figure 18. Global Top Eosinophilic Granulomatosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eosinophilic Granulomatosis Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Eosinophilic Granulomatosis Treatment Revenue in 2020
Figure 20. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Eosinophilic Granulomatosis Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Eosinophilic Granulomatosis Treatment Market Share by Type (2016-2027)
Figure 24. North America Eosinophilic Granulomatosis Treatment Market Share by Application (2016-2027)
Figure 25. North America Eosinophilic Granulomatosis Treatment Market Share by Country (2016-2027)
Figure 26. United States Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Eosinophilic Granulomatosis Treatment Market Share by Type (2016-2027)
Figure 30. Europe Eosinophilic Granulomatosis Treatment Market Share by Application (2016-2027)
Figure 31. Europe Eosinophilic Granulomatosis Treatment Market Share by Country (2016-2027)
Figure 32. Germany Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Eosinophilic Granulomatosis Treatment Market Share by Region (2016-2027)
Figure 42. China Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Eosinophilic Granulomatosis Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Eosinophilic Granulomatosis Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Eosinophilic Granulomatosis Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Eosinophilic Granulomatosis Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Eosinophilic Granulomatosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca plc Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 62. GlaxoSmithKline LLC Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 63. Baxter Healthcare Corporation Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 64. Genentech Inc Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 66. Koninklijke DSM NV Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 67. Novartis International AG Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 68. Pharma Holdings Revenue Growth Rate in Eosinophilic Granulomatosis Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

好酸球性食道炎治療薬のグローバル市場2021

Global Eosinophilic Esophagitis Drug Sales Market Report 2021
QAF27670 2021年4月2日 149Pages
本市場調査資料では、世界の好酸球性食道炎治療薬市場について種類別（ブデソニド、フルチカゾン、その他）、用途別（病院、診療所、ドラッグストア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

好酸球性食道炎治療薬のグローバル市場2021 Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosi…
世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
世界の副甲状腺機能低下症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypoparathyroidism Treatment Market The global Hypoparathyroidism Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…